<DOC>
	<DOC>NCT01003483</DOC>
	<brief_summary>The purpose of this study is to compare the influence of Orlistat and Metformin on obesity treatment in obese PCOS women.</brief_summary>
	<brief_title>Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients</brief_title>
	<detailed_description>In a randomized clinical trial study, 80 obese women with BMIâ‰¥30, oligomenorrhae, hirsutism and presence of &gt; 12 ovarian follicles (2-10mm diameter), were evaluated. In metformin group , metformin was administered for patients 1500 mg daily for three months. In orlistate group, patients used orlistat tablets (120 mg, 3 times a day) for three months. BMI, serum LH and FSH levels, serum triglyceride and cholesterol levels and also patients' ovulation was compared before and after treatment.</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Orlistat</mesh_term>
	<criteria>BMI&gt;= 30 PCOS Drug use during last three months</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>metformin</keyword>
	<keyword>orlistat</keyword>
	<keyword>pcos</keyword>
	<keyword>obese</keyword>
</DOC>